Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Rexahn Pharmaceuticals Inc.
DescriptionHIF-1alpha inhibitor
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionHypoxia-inducible factor 1 alpha (HIF-1 alpha) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today